Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy

Hyungwoo Cho, Dok Hyun Yoon, Kyu pyo Kim, Kyun Seop Bae, Won Seog Kim, Hyeon Seok Eom, Jin Seok Kim, Jung Yong Hong, Seok Jin Kim, Hyewon Lee, Soo Jeong Kim, Cheolwon Suh

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences